Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-25 Purchase | 2023-10-27 4:15 pm | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director 10% Owner | 7,933,601 | $0.7568 | $6,004,149 | 14,992,741 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-27 Disposition | 2024-02-28 5:29 pm | 2022-06-17 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 15,000 | $0 | 4,411 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-28 5:29 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 4,411 | $0 | 4,411 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:10 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:12 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:01 pm | N/A 2032-06-02 | Entrada Therapeutics Inc. | TRDA | Nuechterlein Carole Director | 11,918 | $0 | 11,918 (Direct) | View |
| 2021-10-28 Option Award | 2021-11-01 7:00 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | Nuechterlein Carole Director | 23,552 | $0 | 23,522 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 5:09 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 3,092,340 | $0 | 3,092,340 (Indirect) | View |
Ownership | 2020-10-15 5:13 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 0 | $0 | 3,092,340 (Indirect) | View |
| 2020-06-22 Option Award | 2020-06-23 07:07 am | N/A 2030-06-21 | Millendo Therapeutics Inc. | MLND | Nuechterlein Carole Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-21 4:39 pm | N/A 2029-06-19 | Millendo Therapeutics Inc. | MLND | Nuechterlein Carole Director | 12,000 | $0 | 12,000 (Direct) | View |